699 results about "Avermectin" patented technology

The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.

The invention discloses an insect killing compound containing chlorantraniliprole, which is prepared by two effective ingredients A and B. The ingredient A is chlorantraniliprole, the ingredient B is one of high-efficiency cypermethrin, trifluoro-cypermethrin, dursban, profenofos, dipterex, diafenthiuron, chlorfenapyr, emamectin benzoate, pleocidin, tebufenozide, hexaf lumuron, chlorfenapyr, pyridaben, acetamiprid, isoprocarb, dimehypo and cartap, and the composed mass ratio of the effective ingredient A to the ingredient B is 1:60-60:1. The accumulated mass percent of the two ingredients A and B accounts 1%-85% of the total mass of the compound. In the invention, the blending of the two active ingredients is utilized, so that the effect is improved obviously, the dosage of effective ingredients is reduced, and the drug resistance of insects and mites on the chlorantraniliprole is delayed. The insect killing compound can be used controlling various insects on rice, cotton, vegetables, fruit trees and the like.

The present invention provides for, inter alia, novel topical formulations comprising at least one 1-N-arypyrazole derivative and amitraz and to methods for treating, controlling, or preventing parasite infestations on mammals or birds The inventive formulations include spot-on, pour-on or spray formulations and may include a further ectoparasiticide, such as an IGR compound, an avermectin or milbemycin derivative, or a pyrethroid insecticides, and anthelmintics, such as benzimidazoles and imidazothiazoles. The inventive formulation provides a larger duration of parasite control at a faster rate of control. The inventive formula remains effective up to three months from the first application. Moreover, the inventive formulations prevent tick attachment to the animal, thereby providing protection against tick borne diseases. The ectoparasites which may be controlled, treated or prevented by the present invention includes ticks, fleas, mites, mange, lice, mosquitoes, flies and cattle grubs.

The invention discloses an ultra-low-capacity liquid preparation containing thiamethoxam, which uses thiamethoxam, or the compound of thiamethoxam and active component II as the active ingredient, and supplements the rest to 100% with auxiliary agents and solvents. Low-volume liquid preparation; active component II is beta-cypermethrin, pymetrozine, chlorantraniliprole, flubendiamide, tofenpyrad, azadirachtin, buprofezin, abamectin, and emamectin Any one of plain benzoate and diazinon. The invention can be used to control crop pests such as rice planthopper, rice leaf roller, brown planthopper, white-backed planthopper, striatellus striatellus, stem borer and rice thrips, and has the advantages of convenient processing, water saving, high work efficiency and good drug effect , long-lasting, synergistic and other advantages.

A compound represented by the general formula (I) or a salt thereof:whereinrepresents —CH═CH—, —CH2—CH2— or the like,between R1 and the carbon atom at 4′-position represents a single bond or a double bond,between R2 and the carbon atom at 5-position represents a single bond or a double bond, and for example, 1) whenrepresents —CH═CH— or —CH2—CH2—, andbetween R1 and the carbon atom at 4′-position represents a double bond, R1 represents ═C(R11)(R12) (wherein R11 represents a lower alkyl group or the like and R12 represents a hydrogen atom or the like) or the like, and R2 represents a hydroxyl group or the like, or R2 may be combined together with the carbon atom at 5-position to form a carbonyl group, and 2) whenrepresents —CH═CH— or —CH2—CH2—, andbetween R1 and the carbon atom at 4′-position represents a single bond, R1 represents —OCH(R1a)(R1b) (wherein R1a represents a lower alkyl or the like and R1b represents a hydrogen atom or the like) or the like, and R2 represents a hydroxyl group or the like.

Pharmaceutical / dermatological emulsions containing at least one avermectin compound, notably ivermectin, include at least one fatty phase and at least one aqueous phase, the at least one avermectin compound being solubilized in the fatty phase, which emulsions are useful for the treatment of a variety of dermatological conditions / afflictions, in particular rosacea.

The invention discloses an avermectin microcapsule suspending agent and a preparation method thereof. The avermectin microcapsule suspending agent mainly comprises the following components in percentage by weight: 1 to 10 percent of avermectin, 5 to 40 percent of solvent, 1 to 8 percent of capsule wall material, 0.1 to 3 percent of protection glue, 2 to 5 percent of emulsifier, 3 to 5 percent of dispersant, 0 to 14 percent of adjuvant, and the balance of water. The preparation method for the avermectin microcapsule suspending agent comprises the following steps of: preparing avermectin microcapsules from an avermectin active substance serving as capsule cores and a carbamide resin serving as the capsule wall material by using an interfacial polymerization technology, and finally blending to obtain a microcapsule water suspending agent. Active ingredients of the avermectin microcapsule suspending agent are centralized in the capsule cores, and other media are almost water, so the environmental pollution is reduced and the production cost of products is also effectively reduced. The avermectin microcapsule suspending agent has the release control capacity and can prolong effective duration of pesticides by 3 to 10 times, so that the acute toxicity of technical materials is reduced and the toxicity of a preparation on non-target organisms is also reduced. The avermectin microcapsule suspending agent is safe to use and transport.

The invention relates to a macrolide compound ultralow volume formulation. An active component I and an active component II are used as active components with the addition of a solvent and an auxiliary agent to prepare the ultralow volume liquid formulation, Wherein the active component I contains one or more ingredients selected from the group consisting of a macrolide compound avermectin, emamectin benzoate and ivermectin; the active component II contains one or more ingredients selected from the group consisting of chlorantraniliprole, flubendiamide, metaflumizone, ethiprole, indoxacarb, spinosad, spinetoram, guinalphos and basudin; the content of the active component I is 0.1-5% and the content of the active component II is 0.1-20%; and the cotoxicity coefficient calculated according to Sunyunpei method. The invention is suitable for ultralow volume spraying, low volume spraying and electrostatic spraying, and has advantages of high work efficiency, fast effectiveness, long persistent period, water saving, cooperative synergism and the like.

The invention relates to an agricultural insecticidal composition, in particular to an insecticidal composition consisting of propylene glycol alginate and nitenpyram or avermectin or methylamine avermectins benzote. The insecticidal composition containing the propylene glycol alginate comprises an A active component and a B active component, wherein the A component comprises 0.1-30 percent of the propylene glycol alginate; the B component comprises the components in percentage by weight: 0.5-40 percent of the nitenpyram or the avermectin or the methylamine avermectins benzote, 10-50 percent of additive and 5-50 percent of excipient. The insecticidal composition containing the propylene glycol alginate has the advantages of low use cost, friendliness to a human body and the environment, long persistent period and different resistance generation and also enhances the utilization ratio of drug effective components.